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T
he prevalence of obesity continues to increase
worldwide and represents one of the most press-
ing public health issues due to its associated
morbidity, mortality, and health care costs. Novel
research is demonstrating that alterations of the maternal
environment can impact the intrauterine development of
the fetus and inﬂuence the offspring’s risk for obesity and
type 2 diabetes over the lifecourse. This article reviews
the epidemiological evidence with a focus on the fetal
overnutrition hypothesis. We discuss potential mechanisms
and suggest future directions for research.
THE FETAL OVERNUTRITION PATHWAY TO OBESITY
While postnatal lifestyle is the most immediate cause of
obesity, the inﬂuence of the maternal in utero environment
is evidenced in the U- or J-shaped relationship between
birth weight and adult obesity and metabolic disease dem-
onstrating that both a nutritionally limited or excessive in
utero environment can lead to postnatal obesity and re-
lated chronic diseases. Developmental biology has taught us
about the role of a mismatch between a constrained pre-
natal and a plentiful postnatal environment in the patho-
genesis of obesity, i.e., a so-called thrifty obesity pathway
(1). This is likely operating in developing countries and
populations undergoing rapid transition. Another develop-
mental pathway to obesity, which is likely more important
in Western societies, is the fetal overnutrition pathway.
This pathway reﬂects the effects of hypernutrition during
fetal life and creates the conditions for the later patho-
physiological effects of an obesogenic environment (1).
Although these developmental mechanisms are likely dis-
tinct, they are both associated with an increased risk of
obesity later in life. This article focuses on the fetal over-
nutrition pathway.
Research in this ﬁeld started with the hypothesis of fuel-
mediated teratogenesis (2) and clinical studies suggesting
that offspring exposed to diabetes in utero have greater
birth weight and greater weight for length during childhood.
Animal studies have demonstrated that the metabolic im-
printing caused by the obese and diabetic intrauterine en-
vironment can be transmitted across generations. It has
been suggested that a “vicious cycle” results, explaining the
increases in obesity, gestational diabetes mellitus (GDM),
and type 2 diabetes seen over the past several decades (3).
LONG-TERM CONSEQUENCES OF EXPOSURE TO
MATERNAL DIABETES IN UTERO
Childhood growth, obesity, and the role of postnatal
environment. The role of exposure to diabetes in utero on
infant and childhood growth has been examined in several
studies. The offspring of Pima Indian women with pre-
existent type 2 diabetes and GDM were larger for gestational
age at birth, and, after approximately 5 years of age, were
heavier than the offspring of prediabetic or nondiabetic
women (4). The Diabetes in Pregnancy study in Chicago has
also reported excessive growth in multiethnic offspring of
women with type 1 diabetes during pregnancy (5).
Similar, though somewhat less conclusive, ﬁndings were
noted among youth of Caucasian origin in the Growing Up
Today Study (6) and in the Avon Longitudinal Study of
Parents and Children (ALSPAC) (7). Recently, the Explor-
ing Perinatal Outcomes among Children (EPOCH) study
found that exposure to maternal GDM was associated with
higher BMI, waist circumference, both visceral and sub-
cutaneous adipose tissue, and a more centralized fat dis-
tribution pattern in 6- to 13-year-old multiethnic youth (8).
Moreover, youth exposed to maternal GDM in utero had an
overall higher average BMI growth trajectory from 27
months through 13 years of age (Fig. 1) and higher BMI
growth velocity starting at age 10 to 13 years (9). Impor-
tantly, no signiﬁcant differences in growth trajectories
between exposed and unexposed offspring were noted in
infancy and early childhood (Fig. 2). These ﬁndings sug-
gest that the long-term effects of in utero GDM exposure
are not always evident in early childhood, but rather emerge
during puberty, another sensitive period for the develop-
ment of obesity.
The window for programming appears to extend into
postnatal life. The early postnatal weeks of life, a time
when breast-fed infants often lose weight and formula-fed
infants tend to gain weight, are a crucial period for de-
termining childhood adiposity (10). For offspring of preg-
nancies that carry a high risk for future obesity, early
infant diet may represent an opportunity to inﬂuence long-
term consequences. The EPOCH study recently demon-
strated that offspring who were exposed to GDM and were
breastfed for more than 6 months had lower overall and
central adiposity measures at 6–13 years of age than those
breastfed for ,6 months (11). Since breastfeeding was
also shown to protect against development of type 2
diabetes in the offspring in other reports (12), it follows
that it may also attenuate the increased risk of type 2
diabetes associated with in utero exposure. These data
suggest, as Plagemann and Harder (13) have recently
stated, that “. we have to extend the historical concept
of fuel-mediated teratogenesis beyond birth.”
Glucose abnormalities and type 2 diabetes. In the
Chicago Diabetes in Pregnancy study (5), 12-year-old off-
spring of mothers with type 1 diabetes and GDM had a sig-
niﬁcantly higher prevalence of impaired glucose tolerance
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PERSPECTIVES IN DIABETESthan a nonconcurrent age- and sex-matched control group.
Similarly, at every age before 20 years, offspring of Pima
Indian women with type 2 diabetes and GDM had more
type 2 diabetes than those of prediabetic and nondiabetic
women (4). The higher rate of diabetes was partially me-
diated by the earlier development of obesity, but that did
not account for the magnitude of the difference seen.
Moreover, maternal diabetes was the strongest single risk
factor for type 2 diabetes in Pima Indian youth, accounting
for 40% of type 2 diabetes in that population (14). Indeed,
among the Pima Indian children, the increase in the prev-
alence of type 2 diabetes was accounted for by the in-
crease in the frequency of diabetic pregnancies (14), thus
closing the postulated vicious cycle by which “diabetes
begets diabetes.”
Data from the SEARCH Case-Control Study (15) pro-
vided novel evidence that intrauterine exposure to ma-
ternal diabetes and obesity are important determinants of
FIG. 1. Mean BMI curves for youth both exposed and unexposed to maternal diabetes in utero from 27 months of age to 13 years, adjusted for sex
and race/ethnicity. From Crume et al., J Pediatrics 2011 (9), with permission.
FIG. 2. Mean BMI curves for youth both exposed and unexposed to maternal diabetes in utero from birth to 26 months of age, adjusted for sex and
race/ethnicity. From Crume et al., J Pediatrics 2011 (9), with permission.
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bined exposure to maternal diabetes and obesity in utero
accounted for 47% of the type 2 diabetes risk in the young
offspring. Similar data were recently reported among
young adults from Denmark exposed to maternal type 1
diabetes in utero (16), suggesting that the long-term effects
of exposure are similar regardless of diabetes type.
Despite mounting evidence that exposure to diabetes in
utero is associated with type 2 diabetes in the offspring
and may be responsible for the earlier onset of what was
considered, until recently, a disease of adulthood, very
little is known about how this exposure inﬂuences the
metabolic abnormalities that are precursors of type 2
diabetes. Studies in newborns of diabetic mothers have
shown an enhanced insulin secretion to a glycemic stim-
ulus and b-cell hyperplasia (17). Impaired insulin secretion
has also been proposed as a possible mechanism. Whether
this is a transient phenomenon or leads to impaired glu-
cose tolerance later in life when insulin resistance becomes
important is still uncertain. Studies in humans are limited.
Among Pima Indian adults, the acute insulin response to
infused glucose was 40% lower in individuals whose moth-
ers had diabetes during pregnancy than in those whose
mothers developed diabetes after the birth of the subject
(18). Longitudinal cohort studies are needed to explore
how diabetes exposure in utero inﬂuences metabolic
abnormalities that are predictors of type 2 diabetes.
Cardiovascular risk factors. Animal studies have shown
that exposure to diabetes in utero can induce cardiovas-
cular dysfunction in the fetus and the adult offspring.
However, few human studies have examined the effect of
a diabetic intrauterine environment on cardiovascular risk
factors in the offspring.
By 10–14 years of age, offspring of diabetic pregnan-
c i e se n r o l l e di nt h eC h i c a g os t u d yh a dh i g h e rb l o o d
pressure than offspring of nondiabetic pregnancies (19).
Similar results were noted among 7- to 11-year-old Pima
Indian offspring, independent of adiposity (20). Higher
concentrations of markers of endothelial dysfunction
(intracellular adhesion molecule-1, vascular cell adhesion
molecule-1, E-selectin), as well as increased cholesterol-to-
HDL ratio were also reported among offspring of mothers
with type 1 diabetes compared with offspring of non-
diabetic pregnancies, indep e n d e n to fc u r r e n tB M I( 2 1 ) .
Similarly, EPOCH offspring exposed to maternal GDM had
signiﬁcantly increased E-selectin, vascular cell adhesion
molecule-1, and systolic blood pressure, and decreased
adiponectin levels compared with nonexposed children
(22). Together, these data suggest that in utero exposure
to diabetes confers risks for the development of cardio-
vascular disease later in life that are independent of adi-
posity and may be in addition to genetic predisposition to
diabetes. Studies are needed to explore the mechanisms
through which exposure to diabetes in utero inﬂuences
cardiovascular risk in the offspring.
IS MATERNAL OBESITY IMPORTANT IN THE VICIOUS
CYCLE OF OBESITY?
There is increasing interest in the hypothesis that ma-
ternal obesity is associated with lifelong obesity and re-
lated metabolic consequences in offspring because “the
obesity epidemic could accelerate through successive gen-
erations independent of further genetic or environmental
factors” (23).
Epidemiological data suggest a direct association between
maternal prepregnancy BMI and fetal growth, offspring
BMI, or obesity in later life (24). Children exposed to ma-
ternal obesity are also at increased risk of developing type
2 diabetes (15). Moreover, studies have found that higher
gestational weight gain (GWG) is associated with higher
weight for height in infancy, childhood, and adolescence
(25), with some suggestion that this association is stronger
in obese mothers. These data suggest that increasing
trends of maternal weight and GWG may generate an in-
tergenerational vicious cycle of obesity and diabetes be-
cause heavier mothers give birth to heavier daughters,
who are at increased risk to be obese themselves during
their reproductive years, thus perpetuating the cycle. It
remains to be determined whether improved weight gain
patterns can be achieved throughout pregnancy that would
prevent the short- and long-term consequences on the
offspring described here.
WHAT IS THE ROLE OF MATERNAL DIET?
The role of maternal diet on fetal overnutrition has been
less studied than its relationship with fetal undernutrition.
However, several studies suggest that high energy intakes
resulting in maternal obesity, and diets high in fat, cho-
lesterol, and carbohydrates may inﬂuence fetal growth and
development and have programming consequences. Off-
spring of rats on a high-fat diet had increased pancreatic
b-cell mass, replication, and neogenesis, leading to hy-
perglycemia and type 2 diabetes in the adult life (26).
Other experimental data in animals have shown that the
consumption of a diet rich in saturated fat starting before
conception and continuing through weaning leads to in-
creased hyperinsulinemia, adiposity, hypertension, and en-
dothelial dysfunction in offspring at 6 months of age (27).
AMP-activated protein kinase signaling pathways were
shown to be downregulated, and skeletal muscle develop-
ment was impaired in fetuses of obese, overnourished sheep
(fed 150% of National Research Council recommendations)
(28).
In humans, limited evidence suggests that maternal nu-
tritional intake is associated with maternal insulin resis-
tance and fetal weight. Clapp et al. (29) demonstrated that
infants of mothers on high-glycemic index diets had higher
birth weight and skinfold thickness than those exposed to
a low-glycemic diet. Additional research is needed to un-
derstand whether maternal diet and speciﬁc nutrient in-
takes during pregnancy have effects on neonatal growth,
body composition, and metabolism that can be speciﬁcally
targeted by future interventions.
EVIDENCE FOR SPECIFIC INTRAUTERINE EFFECTS
Several mechanisms that are not mutually exclusive may
explain the associations between exposure to maternal
diabetes/obesity in utero and long-term metabolic out-
comes in the offspring. These include shared genes, shared
familial socioeconomic and lifestyle factors, as well as
speciﬁc intrauterine effects.
Type 2 diabetes is a disease with familial clustering and
clearly has a genetic component. In particular, early-onset
(,35 years of age) type 2 diabetes is associated with
a more severe insulin secretion defect than older-onset
diabetes, suggesting that there may be genes associated
with both early-onset diabetes and more pronounced re-
duction in glucose-stimulated insulin secretion. Similarly,
a strong body of literature suggests that BMI variability
within a population is largely due to heritable genetic dif-
ferences.
D. DABELEA AND T. CRUME
diabetes.diabetesjournals.org DIABETES, VOL. 60, JULY 2011 1851However, work from the Pima Indian population indi-
cates that the effect of maternal diabetes on offspring long-
term outcomes is not fully explained by genetic factors.
Dabelea et al. (30) compared outcomes in siblings dis-
cordant for intrauterine exposures. Among 21 of the 28
Pima sib pairs discordant both for type 2 diabetes and
diabetes exposure in utero, the diabetic sibling was born
after the mother’s diagnosis of diabetes, and in only 7 of
the 28 pairs, the diabetic sibling was born before (odds
ratio 3.0, P , 0.01) (30). Moreover, in this study the mean
BMI in Pima Indian siblings born after the onset of the
mother’s diabetes was signiﬁcantly higher (by 2.6 kg/m
2)
than among age-matched siblings who were not exposed
to diabetes in utero (30). In another study, the prevalence
of obesity among 2- to 18-year-old siblings born after ma-
ternal bariatric surgery was 52% lower than among age-
matched siblings born when their mother was obese (31).
Because siblings discordant for intrauterine exposures
carry a similar risk of inheriting the same susceptibility
genes and share a similar postnatal environment, such
studies provide strong evidence that the excess risk of
childhood obesity and type 2 diabetes associated with fetal
overnutrition reﬂects a speciﬁc intrauterine effect.
WHAT ARE THE SPECIFIC INTRAUTERINE EFFECTS?
The mechanisms responsible for these effects are not
clearly understood but represent an area of intense re-
search, spanning from animal models to human epide-
miological and mechanistic studies and, more recently,
epigenetic research. Although considerable progress has
been made toward a better understanding of how fetal
overnutrition operates, there are still numerous unan-
swered questions and opportunities for future research.
What is the role of maternal fuels?
Hyperglycemia. The fuel-mediated teratogenesis hypoth-
esis was ﬁrst proposed to explain the association between
maternal hyperglycemia in pregnancy and excessive growth
in the developing fetus. While maternal glucose freely
crosses the placenta to the fetus, maternal insulin does
not. The developing fetal pancreas responds to the glucose
load by producing additional insulin, which in turn acts as
a fetal growth hormone promoting growth and adiposity.
Maternal hyperglycemia, extreme enough to be recog-
nized as GDM, is a clear risk factor for macrosomia. How-
ever, most macrosomic infants are not born to mothers
diagnosed with GDM. Several studies suggest that the re-
lation between glycemia during pregnancy and infant body
size is linear. In a study of 6,854 consecutive pregnant
women screened for GDM, increasing glucose concentra-
tion at screening was associated with higher prevalence of
macrosomia (32). In a large community-based study in
Mysore, South India, maternal fasting glucose at 30 weeks
of gestation was positively associated with infant birth
weight, ponderal index, and head circumference (33). In
the multinational Hyperglycemia and Adverse Pregnancy
Outcomes (HAPO) study, there was a linear association
between maternal glucose levels during pregnancy and
macrosomia, serum C-peptide, and neonatal adiposity,
without evidence of a speciﬁc cut point (34), indicating
the need to reconsider current GDM diagnostic criteria.
Although the immediate effects of maternal glucose on
fetal growth are well described, the long-term consequences
on the offspring are less clear. A recent analysis of the
HAPO study found no relationship between maternal glu-
cose levels and child obesity at age 2 years (35). However,
Hillier et al. (36) reported a dose-response relationship
between levels of maternal hyperglycemia in pregnancy
and offspring obesity at age 5–7 years in a retrospective
cohort study of 9,439 Kaiser Permanente mother-child
pairs, even after controlling for GWG. Chandler-Laney
et al. (37) also found a dose-response relationship between
maternal glucose concentrations during pregnancy and
prepubertal offspring lean and fat mass (P , 0.001).
However, in a recent follow-up study (38) of a randomized
clinical trial in Australia, intensive treatment of mild GDM
during pregnancy did not result in BMI differences in off-
spring at 4–5 years of age, although it substantially re-
duced macrosomia, raising doubts about the effectiveness
of a pregnancy intervention based on tight glycemic con-
trol in preventing childhood obesity. There are several
alternative explanations for this negative result. As sug-
gested by EPOCH, it is possible that the effects of expo-
sure to diabetes in pregnancy on offspring BMI only
become apparent during early adolescence when exposed
offspring transition through puberty (9). It is also possible
that the detrimental effects of in utero exposures are af-
fecting other markers of fatness than BMI, especially early
in life. Finally, it is likely that future pregnancy inter-
ventions need to control for the effects of other fuels, in
addition to glucose, which may be altered in obese and
diabetic pregnancies and may have programming con-
sequences.
Other fuels. Descriptive evidence suggests that alter-
ations in maternal lipid metabolism may also contribute to
the fuel-mediated teratogenesis. Free fatty acids (FFAs)
and triglycerides have been shown to be increased in
mothers of obese neonates and because of the limited de
novo lipogenic capacity of the fetus, most precursors for
fetal fat accretion are supplied by transplacental transfer
of maternal substrates derived from lipids. Placental lipo-
protein lipase hydrolyzes triglycerides to FFA that can
then be transferred to the fetus. Lipids play a role in adi-
pocyte differentiation, therefore increased FFA transfer
could affect fetal adiposity by inﬂuencing the number, size,
or lipoprotein lipase activity of fetal fat cells. Limited stud-
ies in humans suggest that, in well-controlled GDM preg-
nancies, maternal lipids are strong predictors for fetal lipids
and fetal growth (39). Epidemiological, clinical, and mech-
anistic studies are needed to test the hypothesis that pro-
gramming of adiposity is, at least in part, mediated through
an abnormal maternal lipid supply to the fetus.
What is the role of the adipoinsular axis? The adi-
poinsular axis is an endocrine feedback loop that connects
the endocrine pancreas with adipose tissue and the brain
to regulate hunger and fat storage through the hormones
insulin and leptin. Insulin promotes development of fat
mass and leptin production, while leptin acts to reduce
energy intake and also suppresses insulin secretion via
leptin receptors on pancreatic b-cells. Abnormal func-
tioning of this feedback loop may therefore lead to excess
adiposity, hyperphagia, and dysregulation of the energy
balance regulating systems (40) (Fig. 3).
Hyperinsulinemia has been reported in fetuses exposed
to diabetes in utero. High amniotic ﬂuid insulin levels are
associated with increased obesity and impaired glucose
tolerance in children exposed to a diabetic intrauterine
environment (5). Fetal hyperinsulinemia is adipogenic in
late fetal and early infant life and is hypothesized to in-
crease both fat cell number and size. Animal studies have
also suggested that fetal hyperinsulinemia may lead to
permanent morphological changes within central nervous
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manent dysplasia and pronounced neuronal hypotrophy
have been shown to occur within the ventromedial hy-
pothalamic nucleus as a result of exposure to increased
insulin concentrations during fetal development (41). Per-
manent disruption of hypothalamic structures has been
demonstrated in animals treated with insulin peripherally
or intrahypothalamically (42). No studies in humans have
speciﬁcally explored these mechanisms.
In addition to the alterations described in fetal insulin
secretion, there is evidence that fetal leptin concentrations
are affected by maternal diabetes during pregnancy. Fetal
leptin is produced by adipocytes and by the placenta, and
cord blood concentrations positively correlate with birth
weight and adiposity. Elevated cord blood leptin concen-
trations were found in both infants of type 1 diabetic and
GDM mothers as compared with control subjects (43),
even after controlling for differences in birth weight, sug-
gesting a direct inﬂuence of maternal hyperglycemia on
neonatal fat mass and leptin levels. Exposure to GDM was
associated with both hyperleptinemia and hyperinsulinemia
in the newborn (44). It is possible that exposure to GDM
may lead to increased insulin secretion and adiposity in
the infant despite the rising plasma leptin concentrations,
which are unable to control the release of insulin and
weight gain (44). Leptin resistance or altered leptin signal-
ing in the postnatal life may therefore manifest as an in-
ability of rising plasma leptin concentrations to control the
release of insulin and/or to reduce body size and fat mass.
No human studies have linked insulin and leptin levels at
birth and postnatally to longitudinal measures of obesity
among offspring exposed to overnutrition in utero in or-
der to test these hypotheses.
What is the role of epigenetics? Epigenetic processes
control genetic function without changing DNA sequence.
DNA methylation, genomic imprinting, and chromatin
changes involving modiﬁcations in histones H3 and H4
are types of posttranslational DNA modiﬁcations that re-
sult in differential levels of gene expression without altering
DNA sequence. The epigenome is particularly susceptible
to alterations during gestation because the DNA synthesis
rate is high and the DNA methylation patterning required
for normal tissue development is established during this
period.
Epigenetic modiﬁcations in response to overnutrition
may lead to metabolic imprinting or permanent alterations
in genes involved in the regulation of energy homeostasis.
Several such genes have been shown to be regulated by
DNA methylation and histone modiﬁcations, including
genes for leptin (45), SOCS3 (46), and glucose transporter
(47). Animal studies have characterized an obese pheno-
type in cloned mice that do not transmit obesity to their
progeny through natural mating, indicating that an epige-
netic modiﬁcation rather than a genetic change may be
responsible for producing the obese phenotype. Recently,
Bouchard et al. (48) found maternal hyperglycemia to be
correlated with placental leptin gene DNA methylation
levels. These ﬁndings suggest that that the intrauterine
environment of diabetic and obese women may impact the
epigenome of the offspring and lend support to further
studies in this area.
FUTURE DIRECTIONS FOR RESEARCH
The effects of overnutrition in utero over the lifecourse
may be viewed as a vicious cycle (Fig. 4) (3,23). Children
FIG. 3. Potential pathways linking fetal overnutrition to long-term consequences in the offspring. Modiﬁed from McMillen, Reproduction 2006
(40), with permission.
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during pregnancy are at increased risk of becoming obese
and developing type 2 diabetes at young ages. Many of
these female offspring are already obese and have diabetes
or abnormal glucose tolerance by the time they reach their
childbearing years, thereby perpetuating the cycle. Across
generations, this cycle is likely increasing the risk and/or
accelerating the onset of obesity and type 2 diabetes.
However, the speciﬁc mediators of these long-term
effects and the likely mechanisms through which they
operate remain unclear. Studies on relevant animal models
with rapid translation by human mechanistic studies are
necessary to understand the effects of maternal fuels and
the contributions of maternal diet and body status on
fetal target tissues. With the recent development of high-
throughput methylation proﬁling assays, analysis of DNA
methylation can now provide unique insight into the role
of epigenetics as a mechanistic link between early life
overnutrition and subsequent pathophysiology. The future
of epigenetic therapy holds tremendous potential not only
for individualized health care but also for population-wide
screening, diagnostic, and prevention strategies.
The role of the postnatal environment and the inter-
action between fetal overnutrition and other postnatal
obesogenic environments and/or developmental periods
also requires further study. Longitudinal cohort studies
starting during gestation and spanning childhood and ado-
lescence, such as ALSPAC (7), Project Viva (49), EPOCH
(11), a newly established prebirth cohort in Colorado
(Healthy Start), and, mostly notably, the National Child-
ren’s Study (50) are needed to rapidly translate the
knowledge provided by basic research and to provide the
necessary platform for addressing some of these crucial
questions.
Finally, randomized trials are needed to determine
whether improved weight gain patterns can be achieved
throughout pregnancy that would prevent the conse-
quences on the offspring described in this article. If this
is achievable, it will in turn probably reduce the prevalence
of obesity and type 2 diabetes in the next generation and,
therefore, be beneﬁcial for future generations as well as for
the immediate offspring.
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